Sodium Bicarbonate → (3-(4-((3-(Hydroxymethyl)-3-methylpyrrolidin-1-yl)methyl)-2-methylphenoxy)azetidin-1-yl)(5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)methanone
Reaction equation
Cl.[CH3:2][C:3]1([CH2:8][OH:9])[CH2:7][CH2:6][NH:5][CH2:4]1.[CH3:10][C:11]1[CH:12]=[C:13]([CH:16]=[CH:17][C:18]=1[O:19][CH:20]1[CH2:23][N:22]([C:24]([C:26]2[O:27][C:28]([C:31]3[CH:36]=[CH:35][CH:34]=[CH:33][CH:32]=3)=[N:29][N:30]=2)=[O:25])[CH2:21]1)[CH:14]=O.[Na].[C:38]([O-])(O)=[O:39].[Na+]>ClCCl.C1COCC1>[OH:9][CH2:8][C:3]1([CH3:2])[CH2:7][CH2:6][N:5]([CH2:14][C:13]2[CH:16]=[CH:17][C:18]([O:19][CH:20]3[CH2:23][N:22]([C:24]([C:26]4[O:27][C:28]([C:31]5[CH:32]=[CH:33][C:34]([O:39][CH3:38])=[CH:35][CH:36]=5)=[N:29][N:30]=4)=[O:25])[CH2:21]3)=[C:11]([CH3:10])[CH:12]=2)[CH2:4]1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
Intermediate 84A (0.095 g, 0.63 mmol) was dissolved in dichloromethane (6 mL), THF (1 mL) and TEA (0.106 mL, 0.76 mmol). Intermediate 74A (0.120 g, 0.31 mmol) was added and the mixture stirred at RT for 5 min. and then sodium triacetoxyhydroborate (0.129 g, 0.61 mmol) was added. The mixture was stirred at RT for 21 h. Aqueous NaHCO3 (8%, 6 mL) was added and the mixture was filtered through a phase separator, dichloromethane (4 mL) was added and the solvent was removed by evaporation. The product was purified by preparative HPLC under basic conditions followed by lyophilisation to give (0.106 g, 71%). 1H NMR (400 MHz, CDCl3) δ 1.01 (s, 3H), 1.57-1.71 (m, 1H), 1.95-2.42 (m, 6H), 2.8-3.09 (m, 2H), 3.3-3.41 (m, 1H), 3.44-3.59 (m, 3H), 3.89 (s, 3H), 4.27-4.38 (m, 1H), 4.59-4.83 (m, 2H), 5-5.22 (m, 2H), 6.44 (d, 1H), 6.96-7.17 (m, 4H), 8.10 (d, 2H), MS (APCI+) m/z 493 [M+H]+, LC Purity: 91%.
Workup
- stirringThe mixture was stirred at RT for 21 h
- filtrationthe mixture was filtered through a phase separator, dichloromethane (4 mL)
- additionwas added
- customthe solvent was removed by evaporation
- customThe product was purified by preparative HPLC under basic conditions
- customto give (0.106 g, 71%)
Sources & evidence
- ORD record
- ord-331be193dcca4aacadbd7c32a3676c5e
- Source dataset
- uspto-grants-2013_10
- Patent number
- US08546375B2
Reaction notes
Loading…